BG up +0.45% percent Today $BG High is at 89.46 and the Low

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
BG up +0.45% percent Today $BG High is at 89.46 and the Low 88.20 with current volume of 112,597.

Recent News posted below.

Bunge Limited BG other info.
http://investorshangout.com/Bunge-Limited-BG-50276/

BG Bunge Limited Recent Headline News

Archer Daniels Expands in China, Opens Sweetener Facility - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 11:40AM CST
Archer Daniels Midland Company (ADM) inaugurated its previously announced sweetener facility in North China at the port of Tianjin, which overlooks the Yellow Sea.
BG: 88.29 (-0.46), ADM: 51.12 (+0.31), TSN: 40.53 (-0.65), ANFI: 15.90 (+0.30)

Solazyme Repositions Up The Value Chain Amidst Moema's Setback
Kevin Quon - at Seeking Alpha - Sun Nov 09, 10:59PM CST

E: 40.70 (+0.51), BG: 88.29 (-0.46), SZYM: 3.43 (-0.01)

Andersons (ANDE) Plunges as Q3 Earnings Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 3:20PM CST
The Andersons Inc. (ANDE) plunged 18% on reporting a 3% decline in Q3 earnings to 59 cents per share, way short of the Zacks Consensus Estimate of 76 cents.
BG: 88.29 (-0.46), CZZ: 9.03 (-0.34), LMNR: 25.44 (-0.12), ANDE: 54.53 (+0.41)

Archer Daniels Beats Q3 Earnings, Misses on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:20AM CST
Archer Daniels Midland Company (ADM) reported better-than-expected adjusted earnings per share for third-quarter 2014.
BG: 88.29 (-0.46), ADM: 51.12 (+0.31), CVGW: 46.47 (-0.98), ANFI: 15.90 (+0.30)

Companies Release Third Quarterly Results - Research Reports on Avon, BorgWarner, Kellogg, Hanes and Bunge
PR Newswire - Tue Nov 04, 8:15AM CST
Today, Analysts Review released its research reports regarding Avon Products, Inc. (NYSE: AVP), BorgWarner Inc. (NYSE: BWA), Kellogg Company (NYSE: K), HanesBrands Inc. (NYSE: HBI) and Bunge Ltd. (NYSE: BG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7685-100free.
BWA: 55.12 (-0.18), BG: 88.29 (-0.46), AVP: 10.03 (-0.23), HBI: 109.81 (+0.50), K: 63.67 (-0.13)

Grain companies face slowing crop sales, Bunge CEO says
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 1:25PM CDT

BG: 88.29 (-0.46)

Bunge Limited's (BG) CEO Soren Schroder on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:20PM CDT

BG: 88.29 (-0.46)

Bunge Limited (BG) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 8:55AM CDT

BG: 88.29 (-0.46)

Bunge misses Street 3Q forecasts
Automated Insights - Thu Oct 30, 7:01AM CDT
WHITE PLAINS, N.Y. (AP) _ Bunge Ltd. (BG) on Thursday reported earnings of $294 million in its third quarter.
BG: 88.29 (-0.46)

Bunge misses by $0.62, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:31AM CDT

BG: 88.29 (-0.46)

Bunge Reports Third Quarter 2014 Results
PR Newswire - Thu Oct 30, 5:30AM CDT
Bunge Limited (NYSE:BG)
BG: 88.29 (-0.46)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 59.05 (-0.25), HST: 22.62 (-0.11), CRR: 49.10 (+1.02), CAH: 80.37 (-0.29), AMT: 99.35 (-0.60), ACIW: 19.15 (+0.27), GTI: 4.34 (+0.14), IDA: 60.84 (-0.34), CRCM: 8.90 (-0.07), CVRR: 23.02 (-0.10), BGCP: 8.63 (+0.05), GOV: 23.00 (-0.08), DFT: 31.28 (-0.25), APO: 22.83 (+0.20), FIG: 7.64 (+0.03), AMAG: 33.85 (-0.39), HAR: 106.14 (-0.43), AVP: 10.03 (-0.23), EXLS: 28.75 (+0.10), INGR: 80.28 (+0.44), ALU: 3.13 (+0.08), INCY: 68.54 (-2.67), COP: 71.28 (+0.93), GEL: 47.81 (+0.81), COR: 38.04 (-0.37), GTLS: 43.47 (-0.53), BWA: 55.12 (-0.18), CARB: 11.63 (+0.15), GLOP: 23.70 (+0.04), IDCC: 50.90 (+1.23), HEES: 36.87 (-0.31), BCO: 21.54 (+0.29), DST: 99.55 (+0.20), EPD: 37.41 (+0.14), ABMD: 33.24 (-0.24), CEVA: 16.71 (+0.83), BLL: 64.33 (-0.83), GBX: 62.89 (-0.61), GNC: 43.50 (-0.16), CVI: 47.65 (+0.55), ACOR: 33.40 (-0.33), I: 17.85 (+0.02), FCN: 41.07 (-0.02), CRNT: 1.10 (-0.05), DHX: 11.25 (-0.06), BG: 88.29 (-0.46), CME: 85.05 (-0.09), FCH: 10.49 (-0.13), ALLE: 52.11 (-0.01), AUDC: 4.60 (-0.02), APD: 134.74 (-0.79), DBD: 35.12 (-0.06), HGG: 6.22 (+0.06), CBM: 23.15 (-0.21), CNSL: 27.22 (+0.12), ATK: 111.08 (-0.06), ANR: 2.67 (+0.25), CI: 101.54 (-1.17), ABC: 88.49 (-0.59), GG: 20.35 (+1.10)

3 Reasons Solazyme Inc. Stock Will Rise From All-Time Lows
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Oct 29, 1:15PM CDT
Volatility has taken hold of renewable-oils manufacturer Solazyme since it plunged to all-time lows of $5.54 per share earlier this month. One-day gains and losses of several percent have become the new normal as opportunistic investors exit short...
BG: 88.29 (-0.46), AMRS: 2.87 (-0.01), SZYM: 3.43 (-0.01)

Bunge (BG) Stock Downgraded to ‘Neutral’ at JPMorgan Today
at The Street - Tue Oct 28, 8:23AM CDT
Bunge (BG) stock was downgraded to 'neutral' from 'overweight' at JPMorgan.
BG: 88.29 (-0.46)

Downgrade Alert for Bunge (BG)
Comtex SmarTrend(R) - Tue Oct 28, 7:01AM CDT
Bunge (NYSE:BG) was downgraded from Overweight to Neutral at JP Morgan today. The stock closed yesterday at $83.82 on volume of 752,000 shares, below average daily volume of 1.0 million. Bunge (NYSE:BG) has potential upside of 7.9% based on a current price of $83.82 and analysts' consensus price target of $90.45. Bunge shares should encounter resistance at the 50-day moving average (MA) of $84.09 and support at its 200-day MA of $79.25.
BG: 88.29 (-0.46)

Andersons Buys 2 Grain Companies to Expand Corn Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 4:15PM CDT
Andersons (ANDE) has acquired the assets of United Grain and Keller Grain.
BG: 88.29 (-0.46), CZZ: 9.03 (-0.34), LMNR: 25.44 (-0.12), ANDE: 54.53 (+0.41)

Bear of the Day: AGCO (AGCO) - Bear of the Day
Tracey Ryniec - ZACKS - Mon Oct 20, 6:16AM CDT
Bear of the Day: AGCO (AGCO) - Bear of the Day
BG: 88.29 (-0.46), AGCO: 44.16 (+0.07)

Syngenta's Q3 Sales Rise Y/Y, 2014 Sales Growth Maintained - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:59AM CDT
Syngenta AG (SYT), after completing third-quarter 2014, has maintained its full year aggregated sales growth rate of 6%.
BG: 88.29 (-0.46), SYT: 65.05 (-0.20), LMNR: 25.44 (-0.12), ANDE: 54.53 (+0.41)

Bunge Limited Schedules Third Quarter 2014 Earnings Release and Conference Call
PR Newswire - Thu Oct 16, 3:01PM CDT
Bunge Limited (NYSE: BG) will announce its results for the quarter ended September 30, 2014, on Thursday, October 30, 2014, prior to the market opening.
BG: 88.29 (-0.46)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hansa's Idefirix Shows Promise for Kidney Transplants

Updated Category News Views 11

Compelling Progress from Hansa Biopharma Y'know, navigating through the biotech jungle isn't for the faint-hearted. Hansa Biopharma's recent results with Idefirix could just be the beacon of hope for patients struggling on transplant lists. Announced at the ASN Kidney Week—a name that's got weight, by the way—these findings aren't just filling space. They're promising...

Continue Reading
Concierge Hybrid Choice™: Transforming Patient Care

Updated Category News Views 22

A New Way to Nurture Patient Relationships This isn't just another cookie-cutter patient care program rolling out—it’s a genuine shake-up in the way doctors connect with their patients. Rishika Kaundal, MD, a dedicated family medicine physician, is pioneering change in Midlothian, Virginia with her Hybrid Choice™ concierge program. This isn't a fluff piece; it's a...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 21

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Blockchain Boom: Media Market to Hit $3.33B by 2035

Updated Category News Views 35

Blockchain is Not Just for Bitcoin Anymore Who would've thought, right? Blockchain's no longer just the playground for cryptocurrency enthusiasts. Today, it's making waves in the media and entertainment sector. Latest numbers from Credence Research have this market set to explode from $748 million in 2025 to a jaw-dropping $3.33 billion by 2035. Yeah, folks, that's a...

Continue Reading
Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 24

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading
Estrogen Patch Struggles: Menopause Care Needs a Boost

Updated Category News Views 25

Troublesome Estrogen Patch Shortages Hit Hard You'd think getting a prescription filled would be a simple task, right? Well, think again. Midi Health shines a glaring light on how the supposed ease of getting hormone therapy is anything but for many women in 2026. Out of those scrambling for estradiol patches, 44% hit roadblocks in pharmacies, and a third hit an all-out...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 4

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyzon Secures Major Order for Hydrogen Fuel Cell Trucks

Updated Category News Views 90

Hyzon Receives Order for Hydrogen Fuel Cell Electric Trucks Hyzon, an innovator in hydrogen fuel cell systems, has announced an exciting new order for two Fuel Cell Electric Trucks (FCETs). This marks a significant step for the company as it continues to provide sustainable solutions for refuse collection through advanced technology. The order comes from a reputable...

Continue Reading
Heron Therapeutics Reports Impressive Financial Gains for 2024

Updated Category News Views 362

Heron Therapeutics Achieves Remarkable Financial Results Heron Therapeutics, Inc. (Nasdaq: HRTX) has announced its outstanding financial performance for 2024, showcasing impressive results that highlight the company's strategic advancements within the biotechnology sector. The company reported a Q4 2024 GAAP net income of $3.6 million, leading to a profitable year-end...

Continue Reading
Imperative Logistics Group Enhances Next-Flight-Out Services

Updated Category News Views 327

Imperative Logistics Group Expands with DTH Expeditors Imperative Logistics Group has recently made a strategic move by acquiring DTH Expeditors, Inc., a prominent provider in high-touch domestic expedited services. This acquisition significantly enhances Imperative's capabilities in the next-flight-out (NFO) logistics sector, which is increasingly vital in today’s...

Continue Reading
Protecting Your Rights as a Five Below, Inc. Shareholder

Updated Category News Views 95

Understanding Your Rights as a Five Below, Inc. Shareholder As a shareholder, it’s crucial to understand your rights in the corporate landscape. Five Below, Inc. (NASDAQ: FIVE) is a well-known company, and being a shareholder means you have a stake in the success and governance of the organization. If you have been investing in its stocks for a significant period,...

Continue Reading
Jefferies Rates Endesa Shares As Hold with Price Target Insights

Updated Category News Views 53

Jefferies Initiates Coverage on Endesa with a Hold Rating Endesa, S.A. (ELE:SM) (OTC: ELEZY) recently came under the spotlight as Jefferies offered new coverage on the stock, assigning it a Hold rating. The analysts set a price target of EUR21.00, a value derived from the company's financial health and the evolving regulatory landscape in Spain. Jefferies emphasized that...

Continue Reading